TrialJournal of attention disorders2022

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD.

Ann Childress et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.